Famotodine

CHEBI:CHEBI_755218

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
310273
listing_expiration_date
20251231
route
ORAL
dosage_form
TABLET
marketing_category
ANDA
active_ingredient_strength
20 mg/1
product_type
HUMAN OTC DRUG
active_ingredient_name
FAMOTIDINE
unii
5QZO15J2Z8
nui
N0000175784
pharm_class_epc
Histamine-2 Receptor Antagonist [EPC]
pharm_class
Histamine H2 Receptor Antagonists [MoA]
pharm_class_moa
Histamine H2 Receptor Antagonists [MoA]
marketing_start_date
20240115
package_marketing_start_date
20240229
application_number
ANDA215767
brand_name_suffix
Maximum Strength
brand_name_base
Acid Reducer
labeler_name
Allegiant Health
manufacturer_name
Allegiant Health
generic_name
Famotodine
brand_name
Acid Reducer Maximum Strength
product_ndc
69168-445
spl_id
4278178c-460f-449e-8a2e-3829f8c0e845
package_ndc
69168-445-52
package_description
225 TABLET in 1 BOTTLE (69168-445-52)
spl_set_id
5c6c6665-cb0a-41d1-af28-85b4f061bd1b
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class